Facilities
Springfield, NJ Contract Development and Manufacturing Facility
Evergreen's 14,000 square foot manufacturing facility was completed in 2021 in Springfield, NJ to 21 CFR 211 GMP standards. The high-quality Contract Development and Manufacturing Facility was designed to enable innovative drug companies to reliably deliver their products through clinical development and into commercialization!
Here, we can use automated and radiolabeling processes unit dose vial dispensing. The production site serves an ideal logistical location, being located at 15 minutes from the International Airport of Newark. We have 7 commercial-scale production suites for drug production using a variety of isotopes. The main lines are being used for medical applications and research and include a dedicated alpha suite. Our facility staff includes a QA/QC team dedicated as well as a strong logistics to make sure that our products get to our clients on time and at the highest quality standards. We routinely produce multiple alpha and beta emitting RLT drugs.
Springfield, NJ – Administrative Offices
and CDMO Support
Home to the executive and administrative functions of Evergreen Theragnostics. Our Administrative Offices are located right next to our manufacturing facility, and serve as the nerve center for our global operations.
Cranbury, NJ -
Discovery Lab
The Evergreen Discovery lab was opened in August of 2023 in Cranbury NJ and houses a state-of-the-art preclinical facility. This 6,500 sq ft space hosts a fully functional vertically integrated laboratory. The laboratory is designed to cover all areas of preclinical and IND-enabling development of RLT drugs.
The space is divided between the following research groups: Cell biology and radiobiology, responsible for the maintenance and growth of cell lines to build our preclinical models, as well as performing in vitro drug characterization. Chemistry and radiochemistry: responsible for the design and manufacturing of our targeting molecules as well as for the chelation and radiolabeling of our RLT drugs. In vivo pharmacology, responsible for the characterization of RLTs in vivo.
Our Discovery team of scientists work together towards all these steps of drug development to bring our novel ideas "from bench side to bedside".
Basel, Switzerland – Early Clinical Development
The Evergreen Discovery Basel offices opened in 2024 to oversee global clinical development of our innovative medicines.
In Basel, a team of scientists and staff work on the translation and clinical development of our drug candidates. The city of Basel is one of the largest pharmaceutical development hubs and provides an optimal environment for our team to easily access and coordinate our global efforts in clinical trials.
Our Discovery team of scientists work together towards bringing our novel ideas "from bench side to bedside".